Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Mitsubishi Tanabe Looks To Maximize Generic Sales Through New Unit

This article was originally published in PharmAsia News

Executive Summary

Osaka-based Mitsubishi Tanabe Pharma plans to launch Tanabe Pharmaceutical sales company on April 1. Established on the basis of the company's current marketing division, Tanabe Pharmaceutical Trading, the new company will market MTP's 14 generic drugs with a plan to expand to 60-140 drugs and a sales goal of ¥10 billion. MTP focuses its generic drug business on circulatory and digestive pharmaceutical products. (Click here for more - Japanese language



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts